3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Prostatic Neoplasms
3
Neoplasms
3
Non-Muscle Invasive Bladder Neoplasms
2
Lymphoma, B-Cell
2
Carcinoma, Transitional Cell
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Pancreatic Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Histologic Type
1
Neoplasm, Residual
1
Lung Neoplasms
1
Liposarcoma, Myxoid
1
Leukemia, Myeloid, Acute
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
Oxaliplatin
24
Fluorouracil
20
Capecitabine
16
pembrolizumab
15
Nivolumab
15
Leucovorin
13
Trastuzumab
9
fludarabine
8
Paclitaxel
8
Drug Therapy
8
Docetaxel
8
Cyclophosphamide
8
S 1 (combination)
7
trastuzumab deruxtecan
6
Specimen Handling
6
Cisplatin
6
Magnetic Resonance Spectroscopy
5
Bevacizumab
5
zolbetuximab
4
Irinotecan
4
Biopsy
4
zimberelimab
3
sintilimab
3
fludarabine phosphate
3
atezolizumab
3
aldesleukin
3
XELOX
3
Surgical Procedures, Operative
3
Ramucirumab
3
Radiotherapy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Stomach Neoplasms
×
ALT-803
×
90 days
×
Clear all
No trials found.